1. "Blood"
  2. "Cardiology"
Formats
  1. Meeting Abstract (7)
  2. Journal Article (1)
Groups
  1. Cardiology (8)
  2. Center for Hematologic Malignancies (8)
  3. Department of Medicine (8)
  4. Division of Subspecialty Medicine (8)
  5. Hematologic Malignancies, Division of (8)
  6. Survivorship Research (7)

More Groups

People
  1. Sergio Giralt (4)
  2. Wendy Schaffer (4)
  3. Hani Hassoun (3)
  4. Heather Landau (3)
  5. Jennifer Liu (3)
  6. Maria Palomba (3)

More People

Years
  1. 2023 (2)
  2. 2017 (1)
  3. 2016 (2)
  4. 2015 (1)
  5. 2014 (1)
  6. 2007 (1)
Publications
  1. Blood (8)
Publishers
  1. American Society of Hematology (8)

Results (8)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The impact of cardiovascular vulnerabilities in non Hodgkin lymphoma patients treated with chimeric antigen receptor T cell therapy
    Meeting Abstract

    Landego, I.; Flynn, J. R.; Goldman, A.; Devlin, S. M.; Luttwak, E.; Luna De Abia, A.; Corona, M.; Kedmi, M.; Sdayoor, I.; Fried, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Artificial intelligence enabled ECG interpretation informs outcomes after autologous transplantation for multiple myeloma
    Meeting Abstract

    Shaffer, B. C.; Attia, I. Z.; Greason, G.; Chinapen, S.; Brown, S.; Chung, D.; Lahoud, O. B.; Lopez-Jimenez, F.; Schaffer, W.; Liu, J.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A phase Ib/IIa trial of the combination of romidepsin, lenalidomide and carfilzomib in patients with relapsed/refractory lymphoma shows complete responses in relapsed and refractory B-and T-cell lymphomas
    Meeting Abstract

    Mehta-Shah, N.; Moskowitz, A. J.; Lunning, M. A.; Lynch, P.; Scheuerman, M.; Minnal, V.; Galasso, N.; Kumar, A.; Gerecitano, J.; Zelenetz, A. D.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • A Phase Ib/IIa trial of the combination of romidepsin, lenalidomide and carfilzomib in patients with relapsed/refractory lymphoma shows complete responses in relapsed and refractory T-cell lymphomas
    Meeting Abstract

    Mehta-Shah, N.; Moskowitz, A. J.; Lunning, M.; Lynch, P.; Scheuerman, M.; Kumar, A.; Gerecitano, J. F.; Zelenetz, A. D.; Hamlin, P. A. Jr; Noy, A.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Rivaroxaban for stroke prevention in patients with non-valvular atrial fibrillation and active cancer
    Meeting Abstract

    Laube, E. S.; Yu, A.; Gupta, D.; Miao, Y.; Samedy, P.; Wills, J.; Harnicar, S. J.; Soff, G. A.; Mantha, S.
    Blood (2016)

    Fulltext@MSK | Save
  • Induction with bortezomib and dexamethasone (BD) followed by risk adapted high dose melphalan and autologous stem cell transplantation and BD consolidation in patients with AL amyloidosis: A phase II feasibility study
    Meeting Abstract

    Landau, H.; Montanez, N.; Cowan, A.; Hoover, E.; Flombaum, C.; Liu, J.; Maurer, M.; Lendvai, N.; Landgren, O.; Giralt, S. A.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • A phase 2 single-center study of carfilzomib 56 mg/m2 with or without low-dose dexamethasone in relapsed multiple myeloma
    Journal Article

    Lendvai, N.; Hilden, P.; Devlin, S.; Landau, H.; Hassoun, H.; Lesokhin, A. M.; Tsakos, I.; Redling, K.; Koehne, G.; Chung, D. J.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Predictors of survival in de novo cardiac amyloidosis
    Meeting Abstract

    Comenzo, R. L.; Maurer, M.; Cohen, A.; Hassoun, H.; Zhou, P.; Lu, P.; Fleisher, M.; Lebovic, D.; Feldstein, J.; Steingart, R.; more...
    Blood (2007)

    Fulltext@MSK | Save